Emb-Fatol

Emb-Fatol is a pharmaceutical product containing Ethambutol Hydrochloride, used for intravenous administration. It is indicated for the treatment of certain bacterial infections, particularly tuberculosis. This medication is manufactured by Esteve Pharmaceuticals GmbH and is available in the EU market.

Emb-Fatol, containing Ethambutol Hydrochloride, is primarily used for the treatment of tuberculosis, a bacterial infection that primarily affects the lungs. It is often used in combination with other medications to effectively manage and control the infection. Ethambutol Hydrochloride is known for its ability to target and inhibit the growth of the bacteria responsible for tuberculosis, making it a crucial component in the treatment regimen.

Common effects of Emb-Fatol may include changes in vision, such as blurred vision or difficulty distinguishing colors. Some individuals may also experience gastrointestinal issues like nausea or vomiting. It is important to monitor for any visual disturbances and report them to a healthcare provider promptly.

Emb-Fatol should be used with caution in individuals with a history of eye problems or visual impairments. Regular eye examinations are recommended during treatment to monitor for any potential ocular side effects. It is also important to follow the prescribed dosage and administration instructions to minimize the risk of adverse effects.

Emb-Fatol may interact with certain medications, including those that affect liver function or other antibiotics. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using Emb-Fatol, as it may exacerbate certain side effects.